Gene · 25939
NIH grants2,175
NIH grants whose papers are about the gene, through NIH's grant-paper links.
201 to 220 of 2,175
Download this page as JSON| Grant | Title | SAMHD1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI049954 | Gene Transcription in SLE | 1 | 2025 |
| R01AI078881 | Collaborative Integration of HCV Molecular Virology and Mathematical Modeling | 1 | 2025 |
| R01AI095983 | Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial Disease | 1 | 2025 |
| R01AI108834 | GBPs in inflammasome activation and host defense to infection | 1 | 2025 |
| R01AI116868 | NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans | 1 | 2025 |
| R01AI120860 | Development of HIV capsid-targeting antivirals that affect immune response by modulating capsid stability and have improved resistance profiles | 1 | 2025 |
| R01AI121244 | Redefining the role of autophagy in bacterial disease | 1 | 2025 |
| R01AI124690 | Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity | 1 | 2025 |
| R01AI125524 | Kinase Regulation of Nuclear Speckle Function and Splicing during Influenza Virus Infection | 1 | 2025 |
| R01AI125581 | Automated Forward Genetic Analysis of Adaptive Immunity | 1 | 2025 |
| R01AI127465 | Effector-mediated ubiquitin manipulation in Legionella pneumophila pathogenesis | 1 | 2025 |
| R01AI127564 | Genome-wide search for inborn errors of IL-17 immunity underlying chronic mucocutaneous candidiasis | 1 | 2025 |
| R01AI129269 | Olfactory and neurological manifestations of acute and post-acute murine COVID-19 | 1 | 2025 |
| R01AI130025 | Role of the gender biased transcription factor VGLL3 in promoting autoimmune responses in SLE | 1 | 2025 |
| R01AI130089 | Transcriptional Control of Human Cytomegalovirus Latency | 1 | 2025 |
| R01AI130345 | Development of the resident macrophage lineage in mouse and human | 1 | 2025 |
| R01AI150396 | HIV Reservoir Ecology of Viral Remission (PTC) | 1 | 2025 |
| R01AI155131 | HIV-2 latency and its reversal | 1 | 2025 |
| R01AI161444 | Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo | 1 | 2025 |
| R01AI162223 | Single cell transcriptomics of HIV persistence and latency | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25939/grants?page=11